Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$61.23 - $83.62 $171,811 - $234,637
-2,806 Reduced 10.06%
25,090 $1.59 Million
Q3 2022

Nov 14, 2022

SELL
$65.58 - $84.69 $1.2 Million - $1.55 Million
-18,287 Reduced 39.6%
27,896 $2.03 Million
Q2 2022

Aug 11, 2022

BUY
$52.13 - $93.81 $975,821 - $1.76 Million
18,719 Added 68.16%
46,183 $3.14 Million
Q1 2022

May 13, 2022

SELL
$64.92 - $99.47 $136,851 - $209,682
-2,108 Reduced 7.13%
27,464 $2.49 Million
Q4 2021

Mar 11, 2022

BUY
$76.51 - $93.96 $463,956 - $569,773
6,064 Added 25.8%
29,572 $2.7 Million
Q3 2021

Nov 10, 2021

BUY
$71.29 - $95.99 $1.68 Million - $2.26 Million
23,508 New
23,508 $1.91 Million

Others Institutions Holding NARI

About Inari Medical, Inc.


  • Ticker NARI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 53,389,700
  • Market Cap $2.52B
  • Description
  • Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...
More about NARI
Track This Portfolio

Track Bokf, Na Portfolio

Follow Bokf, Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

News

Stay updated on Bokf, Na with notifications on news.